Albert MJ, Mathan VI, Baker SJ. Vitamin B12 synthesis by human small
intestinal bacteria. Nature. 1980;283(5749):781-782.
Ames BN. Micronutrient deficiencies: A major cause of DNA damage. Ann NY
Acad Sci. 2000;889:87-106.
Beaugerie L. [Diarrhea caused by antibiotic therapy]. Rev Prat.
1996;46(2):171-176.
Berger W. Incidence of severe side effects during therapy with sulfonylureas
and biguanides. Horm Metab Res Suppl. 1985;15:111-115.
Carmel R. Current concepts in cobalamin deficiency. Ann Rev Med.
2000;51:357-375.
Carpentier JL, Bury J, Luyckx A, Lefebvre P. Vitamin B12 and folic acid serum
levels in diabetics under various therapeutic regimens. Diabetes Metab.
1976;2(4):187-190.
Covington T, ed. Nonprescription Drug Therapy Guiding Patient
Self-Care. St Louis, MO: Facts and Comparisons; 1999: 467-545.
Elmer GW, Surawicz CM, McFarland LV. Biotherapeutic agents. A neglected
modality for the treatment and prevention of selected intestinal and vaginal
infections. JAMA. 1996;275(11):870-876.
Floor M, van Akkeren F, Rozenberg-Arska M, et al. Effect of loracarbef and
amoxicillin on the oropharyngeal and intestinal microflora of patients with
bronchitis. Scand J Infect Dis. 1994;26(2):191-197.
Galland L. The Four Pillars of Healing. New York, NY: Random House;
1997:186-199.
Gotz V, Romankiewicz JA, Moss J, Murray HW. Prophylaxis against ampicillin
associated diarrhea with a lactobacillus preparation. Am J Hosp Pharm.
1979;36:754-757.
Hill MJ. Intestinal flora and endogenous vitamin synthesis. Eur J Cancer
Prev. 1997;6(Suppl 1):S43-S45.
Lode H, Muller C, Borner K, et al. Multiple-dose pharmacokinetics of
cefprozil and its impact on intestinal flora of volunteers. Antimicrob Agents
Chemother. 1992;36(1):144-149.
Mayer EL, Jacobsen DW, Robinson K. Homocysteine and coronary atherosclerosis.
J Am Coll Cardiol. 1996;27(3):517-527.
McFarland LV, et al. Prevention of Beta-lactam-associated diarrhea by
Saccharomyces boulardi compared with placebo. Am J Gastroenterol.
1995;90(3):439-448.
Murray, M, Pizzorno, J. Encyclopedia of Natural Medicine
2nd ed. Rocklin: Prima Publishing; 1998:435.
Nord CE, Grahnen A, Eckernas SA. Effect of loracarbef on the normal
oropharyngeal and intestinal microflora. Scand J Infect Dis.
1991;23(2):255-260.
Nord CE. The effect of antimicrobial agents on the ecology of the human
intestinal microflora. Vet Microbiol. 1993;35(3-4):193-197.
Novelli A, Mazzei T, Fallani S, et al. Betalactam therapy and intestinal
flora. J Chemother. 1995;7(Suppl 1):25-31.
Olson RE. Vitamin K. In: Shils, ME, Olson JA, Shike, M, eds. Modern
Nutrition in health and disease. 9th ed. Media, PA: Williams & Wilkins;
1999:363-380.
Powers HJ. Current knowledge concerning optimum nutritional status of
riboflavin, niacin and pyridoxine. Proc Nutr Soc. 1999;58(2):435-440.
Schafer H, Naber K, Adam D. [Hemostasis disturbance caused by cephalosporins
with an N-methylthiotetrazole side chain. A randomized pilot study].
Arznimettelforschung. 1989;39(9):1156-1162.
Spurling NW, Harcourt RA, Hyde JJ. An evaluation of the safety of cefuroxime
axetil during six months oral administration to beagle dogs. J Toxicol
Sci. 1986;11(4):237-277.
Stieger R, Baumgartner K, Neff U. [Dangerous hypothrombinemic hemorrhage in
antibiotic therapy]. Helv Chir Acta. 1992;58(6):775-778.
Surawicz CM, Elmer GW, Speelman P, et al. Prevention of antibiotic-associated
diarrhea by Saccharomyces boulardii: A prospecive study.
Gastroenterol. 1989;96(4):981-988.
Vermeer C, Schurgers LJ. A comprehensive review of vitamin K and vitamin K
antagonists. Hematol Oncol Clin North Am. 2000;14(2):339-353.